Location: Owensboro
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Owensboro
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line Phase 3 · Owensboro Medical Health System ( Site 0066) · Merck Sharp & Dohme LLC · NCT06136559 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Phase 3 · Research Site · AstraZeneca · NCT06868277 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc Phase 3 · Owensboro Health Mitchell Memorial Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632327 A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102 A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t Phase 2 · Research Site · AstraZeneca · NCT07525375 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Phase 3 · Owensboro Health Mitchell Memorial Cancer Center · BeOne Medicines · NCT07492641 E-Mindfulness Approaches for Living After Breast Cancer Phase 3 · Owensboro Health Mitchell Memorial Cancer Center · NRG Oncology · NCT06748222 A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma Phase 2 · Allergy & Asthma Specialists, P.S.C. · Eli Lilly and Company · NCT07219173 Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY A Phase 3 · Allergy and Asthma Specialist- Site Number : 8400002 · Sanofi · NCT06191315 Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD Phase 4 · Qualmedica Research, LLC. · Supernus Pharmaceuticals, Inc. · NCT04781140 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer Phase 2/Phase 3 · Owensboro Health Mitchell Memorial Cancer Center · SWOG Cancer Research Network · NCT03851445 A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Pr Phase 3 · Owensboro Medical Health System ( Site 0195) · Merck Sharp & Dohme LLC · NCT06717347 A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Phase 1 · Equity Medical - Owensboro · Bambusa Therapeutics · NCT06944925 An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis Phase 2 · Local Site #840011 · Zomagen Biosciences Ltd. · NCT06836232 A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis Phase 3 · Nektar Investigative Site · Nektar Therapeutics · NCT07690371 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a Phase 3 · Research Site · AstraZeneca · NCT07000357 Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) Phase 3 · Local Institution - 0030 · Bristol-Myers Squibb · NCT07116967 ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults Phase 2 · Enveda Investigative Site · Enveda Therapeutics · NCT07301255 Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Perc Phase 4 · Research Integrity, LLC · Duke University · NCT06909565 A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Phase 3 · Research Integrity Global, LLC · Novo Nordisk A/S · NCT07567001 A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participan Phase 3 · Owensboro Medical Health System · Mirati Therapeutics Inc. · NCT06875310 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D Phase 3 · Research Site · AstraZeneca · NCT06878261 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, Phase 3 · Research Integrity, LLC · Boehringer Ingelheim · NCT07064473 Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention NA · Owensboro Health Mitchell Memorial Cancer Center · Timothy Mullett · NCT07682610 Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation NA · Owensboro Health Mitchell Memorial Cancer Center · Timothy Mullett · NCT07639255 A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneou Phase 3 · Allergy and Asthma Specialist P S C · Novartis Pharmaceuticals · NCT06868212 Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin Phase 3 · Research Site · AstraZeneca · NCT06677060 Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer Phase 3 · Owensboro Health Mitchell Memorial Cancer Center · SWOG Cancer Research Network · NCT05929768 Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to Phase 3 · Owensboro Health Mitchell Memorial Cancer Center · NRG Oncology · NCT06500455 A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard Phase N/A · Allergy & Asthma Specialists, P.S.C. · Regeneron Pharmaceuticals · NCT06693531
Look up another city
Look up another condition